Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Background</h3><p>The high prevalence of dermatophytosis in animals is usually associated with extra expenditure on prevention, diagnosis, and long‐term treatment. Humans are usually infected from animals, also from asymptomatic carriers, through direct contact or indirectly via fungus‐bearing hair, scales, and fomites. Despite the medical importance of <i>Trichophyton verrucosum</i> infections, there are limited <i>in vitro</i> data on the fungal susceptibility to antifungal drugs, including new‐generation triazoles, imidazoles, and allyloamines. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Objectives</h3><p>The aim of the current study was to evaluate comprehensively the <i>in vitro</i> activity of 11 antifungal drugs against a large collection of <i>T. verrucosum</i> isolates obtained in Poland, Latvia, Lithuania, and Slovakia from humans and animals using a microdilution assay. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Methods</h3><p><i>In vitro</i> susceptibility testing of 11 antifungal drugs was performed according to the Clinical and Laboratory Standards Institute (CLSI) document M38. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>The MICs of clotrimazole, ciclopirox, enilconazole, miconazole, naftifine, and terbinafine against all <i>T. verrucosum</i> isolates were below 1 μg/ml, whereas those of fluconazole, griseofulvin, itraconazole, ketoconazole, and voriconazole were above 1 μg/ml. Ciclopirox was demonstrated to have superior activity against all strains in comparison with the other drugs, whereas fluconazole exerted the weakest <i>in vitro</i> effect and exhibited the highest MIC values. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusions</h3><p>Our study has shown that drugs of different chemical origin have satisfactory antifungal activity and can be promising candidates for the treatment of <i>T. verrucosum</i> dermatophytosis. Moreover, no significant disparity in drug sensitivity between isolates obtained from different hosts and geographical regions have been demonstrated. </p></section>

In vitro susceptibility of chromoblastomycosis agents to five antifungal drugs and to the combination of terbinafine and amphotericin B

In Vitro Interaction of Itraconazole with Amphotericin B, Caspofungin, and Terbinafine Against Clinical Isolates of Trichosporon asahii

Chromoblastomycosis: still a therapeutic challenge

In Vitro Activity of Isavuconazole and Amphotericin B in Association against Mucorales

In Vitro Interaction of Terbinafine with Itraconazole and Amphotericin B Against Fungi Causing Chromoblastomycosis in China.

Resazurin to determine the minimum inhibitory concentration on antifungal susceptibility assays for Fonsecaea sp. using a modified EUCAST protocol

Synergistic effect of terbinafine and amphotericin B in killing Fonsecaea nubica in vitro and in vivo

In vitro activities of six antifungal agents and their combinations against Chaetomium spp.

In vitro activity of fluconazole, itraconazole, voriconazole and terbinafine against fungi causing onychomycosis

A Refractory Case of Chromoblastomycosis Due to Fonsecaea Monophora with Improvement by Photodynamic Therapy.

New possibilities for chromoblastomycosis and phaeohyphomycosis treatment: identification of two compounds from the MMV Pathogen Box® that present synergism with itraconazole

Onychomycosis: clinical, mycological and in vitro susceptibility testing of isolates of Trichophyton rubrum

In vitro activities of nine antifungal agents against rare pathogenic fungi.

In Vitro Combined Activity of Amphotericin B, Caspofungin and Voriconazole Against Clinical Isolates of Trichosporon Asahii

In Vitro Activities of a Wide Panel of Antifungal Drugs against Various Scopulariopsis and Microascus Species

Comparison of in vitro activities of 11 antifungal agents against Trichophyton verrucosum isolates associated with a variety hosts and geographical origin

In vitro susceptibilities of 11 clinical isolates of Exophiala species to six antifungal drugs

Comparison of the antifungal activity of the pyrimidine analogs flucytosine and carmofur against human-pathogenic dematiaceous fungi

In vitro antifungal oral drug and drug-combination activity against onychomycosis causative dermatophytes

In Vitro Activities of Nine Antifungal Drugs and Their Combinations against Phialophora verrucosa

In Vitro Activity of Antifungal Drugs Against Trichophyton rubrum and Trichophyton mentagrophytes spp. by E-Test Method and Non-supplemented Mueller–Hinton Agar Plates